Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome

Mucopolysaccharidosis type I (MPS I) was added to the Recommended Uniform Screening Panel for newborn screening in 2016, highlighting recognition that early treatment of MPS I is critical to stem progressive, irreversible disease manifestations. Enzyme replacement therapy (ERT) is an approved treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisengart, Julie B., Jarnes, Jeanine, Ahmed, Alia, Nestrasil, Igor, Ziegler, Richard, Delaney, Kathleen, Shapiro, Elsa, Whitley, Chester
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622996/
https://www.ncbi.nlm.nih.gov/pubmed/28983455
http://dx.doi.org/10.1016/j.ymgmr.2017.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622996/
https://www.ncbi.nlm.nih.gov/pubmed/28983455
http://dx.doi.org/10.1016/j.ymgmr.2017.07.012

Ejemplares similares